Christopher Slapak, MD

Chief Medical Officer, Vor Biopharma

Articles by Christopher Slapak, MD

October 5th 2021

The chief executive and chief medical officers of Vor Biopharma discussed the company’s future research and plans.

September 30th 2021

The chief executive and chief medical officers of Vor Biopharma discussed their focus on AML, CD33, and their lead program VOR33.